My Store
FLM CardioCore
FLM CardioCore
Sudden chest pain, fatigue, shortness of breath, or heart palpitations could signal more than stress they may indicate Fulminant Lymphocytic Myocarditis (FLM), an aggressive form of heart inflammation often caused by viral infection. This in-depth cardiology panel is designed to support rapid diagnosis and monitoring of FLM using venous blood testing and advanced cardiac imaging where necessary.
Couldn't load pickup availability

What Gets Assessed?
-
Cardiac Injury & Stress Markers
- Troponin I or T: Detects cardiac muscle damage
- CK-MB (Creatine Kinase-MB): Indicates acute myocardial injury
- BNP or NT-proBNP: Assesses heart stress or failure severity
- Inflammatory Response
- C-reactive Protein (CRP): Measures general
inflammation - Erythrocyte Sedimentation Rate (ESR): Detects ongoing inflammatory processes
- Procalcitonin: Helps differentiate bacterial vs. viral causes
-
Viral & Autoimmune Screening
- Viral PCR/Serology: Identifies common viral triggers (e.g., Coxsackievirus, Parvovirus B19)
- Autoimmune Panel (ANA, ENA): Rules out autoimmune myocarditis
-
Imaging & Cardiac Function
- Echocardiography: Evaluates heart structure and pumping efficienc
- Cardiac MRI: Detects myocardial inflammation, edema, and fibrosis
-
Advanced Testing (ifindicated)
Endomyocardial Biopsy: Confirms FLM via tissue examination
Complete Blood Count (CBC): Assesses immune cell levels and systemic response
Why FLM CardioCore Test Matters?
FLM is a rare but severe condition that can progress quickly, leading to heart failure or life-threatening arrhythmias if not promptly diagnosed. Because early symptoms can mimic common viral infections, thorough testing is crucial for timely intervention. This panel combines biomarkers, imaging insights, and inflammatory markers to help clinicians confirm diagnosis and manage care effectively.
Why Choose Clinic-Based Blood Testing?
-
Accurate Results
Samples are collected by trained professionals for precise, lab-quality outcomes.
-
Fast Health Insights
Quick, In-clinic testing enables early detection and faster follow-up care.
-
Expert Oversight
Healthcare staff guide the process and help interpret your results.
-
Nationwide Access
Convenient locations across the UK through The National Phlebotomy Clinic.
FAQs
Collapsible content
What is Fulminant Lymphocytic Myocarditis (FLM)?
FLM is a sudden and severe form of myocarditis marked by intense inflammation of the heart muscle, often caused by a viral infection. It requires urgent medical evaluation and treatment.
Who should take this test?
This panel is recommended for individuals with unexplained chest pain, shortness of breath, irregular heartbeat, or who have had recent viral illness followed by cardiac
symptoms.
Is this test used for diagnosis or monitoring?
Both. It aids in diagnosing FLM and tracking response to treatment or disease progression through follow-up testing.
How is the test performed?
Most components are assessed through venous blood collection, supported by imaging tests like echocardiography or cardiac MRI if required.
Can this condition be treated?
Yes. With early diagnosis, FLM can be managed with medications, supportive care, and in some cases, temporary mechanical support for heart function.
Subscribe to our emails
Be the first to know about new collections and exclusive offers.